Literature DB >> 1127254

Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection.

R T Steigbigel, R L Greenman, J S Remington.   

Abstract

A penicillin-sensitive strain of Staphylococcus aureus was used to evaluate the efficacy of six antibiotic combinations in the therapy of an experimental infection in mice. One hour after intraperitoneal infection, animals were treated with penicillin G, erythromycin, clindamycin, gentamcicin, or tobramycin singly or in various combinations of two of these drugs. Penicillin in combination with tobramycin, gentamicin, or ertyromycin significantly reduced mortality was compared with therapy with a single drug. Survival of animals treated with the combinations of penicillin and clindamycin, clindamycin and gentamicin, and erythromycin and gentamicin was not different from that seen with single-drug therapy. Pencillin plus either gentamicin or erythromycin significantly reduced the number of culturable organisms from livers and spleens of infected animals when compared with penicillin, gentamicin, or erythromycin alone. In vitro studies correlaed with some aspects of in vivo results but conflicted with others. Thus the combination of penicillin with either an aminoglycoside antibotic or erythromycin is more effective than a single drug in the therapy of infection caused by the Smith strain of S. aureus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127254     DOI: 10.1093/infdis/131.3.245

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Use of synergistic antibiotics in the treatment of infections.

Authors:  J Righter; H Richardson
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

2.  Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.

Authors:  M H Miller; M A Wexler; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.

Authors:  F D Lowy; J A Walsh; M M Mayers; R S Klein; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

4.  Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.

Authors:  L Coppens; B Hanson; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

5.  Combination antibiotic therapy in an outbreak of prosthetic endocarditis caused by Staphylococcus epidermidis.

Authors:  G W Hammond; H G Stiver
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

6.  In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors:  C U Tuazon; M Y Lin; J N Sheagren
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

7.  In vitro synergy of cefamandole-tobramycin combinations.

Authors:  A J Valenti; A J Siniscalchi; V T Andriole
Journal:  Yale J Biol Med       Date:  1977 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.